Lista de obras - Chiara Fabbri - Dominio Público Uruguay

A model to investigate SNPs' interaction in GWAS studies

artículo científico publicado en 2014

Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors

artículo científico publicado en 2016

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial

artículo científico publicado en 2015

CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study

artículo científico

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

artículo científico publicado en 2018

Clinical features and drug induced side effects in early versus late antidepressant responders

artículo científico publicado en 2013

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

artículo científico publicado en 2016

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy

artículo científico publicado en 2014

Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption

artículo científico publicado en 2020

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank

artículo científico publicado en 2021

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D ⬇️

artículo científico publicado el 11 de agosto de 2012

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.

artículo científico publicado en 2016

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment

artículo científico publicado en 2014

Genes involved in neuroplasticity and stressful life events act on the short-term response to antidepressant treatment: a complex interplay between genetics and environment

artículo científico publicado en 2014

Genetic and Environmental Contribution to Major Depressive Disorder and Self-declared Depression

artículo científico publicado en 2016

Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder

artículo científico publicado en 2018

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

artículo científico publicado en 2011

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future

scientific article published on 01 February 2020

Genetics of long-term treatment outcome in bipolar disorder

artículo científico publicado en 2015

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

artículo científico publicado en 2014

Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes

artículo científico publicado en 2015

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway

artículo científico publicado en 2016

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

artículo científico publicado en 2018

Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders.

artículo científico publicado en 2015

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

artículo científico publicado en 2015

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis

artículo científico publicado en 2015

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach

scientific article published on 01 November 2020

Mechanisms of antidepressant action: an integrated dopaminergic perspective

scientific article published on 11 March 2011

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy ⬇️

artículo científico publicado el 3 de diciembre de 2011

Neuronal cell adhesion genes and antidepressant response in three independent samples

No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression

artículo científico publicado en 2013

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

article

Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials

Pharmacogenetics in major depression: a comprehensive meta-analysis

artículo científico

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

artículo científico publicado en 2013

Pharmacogenetics of antidepressant response

artículo científico publicado en 2011

Pharmacogenetics of antidepressants

artículo científico publicado en 2011

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications

artículo científico

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.

artículo científico publicado en 2017

Precision psychiatry in clinical practice

scientific article published on 27 August 2020

Predictors of switch from depression to mania in bipolar disorder

artículo científico publicado en 2015

Progress and prospects in pharmacogenetics of antidepressant drugs

artículo científico publicado en 2016

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice

artículo científico publicado en 2019

Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics

artículo científico publicado en 2015

Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment

artículo científico publicado en 2013

Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients

scholarly article by Yoshiteru Takekita et al published 2015 in Neuropsychobiology

Shared genetics among major psychiatric disorders ⬇️

artículo científico publicado el 28 de febrero de 2013

Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples

artículo científico publicado en 2013

TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression

artículo científico publicado en 2012

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

artículo científico publicado en 2016

The search for personalized antidepressant treatments: what have we learned and where are we going

scientific article published on 05 October 2020

Uncovering neurodevelopmental features in bipolar affective disorder

artículo científico publicado en 2019

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors

artículo científico publicado en 2014

Lista de obras de Chiara Fabbri

A model to investigate SNPs' interaction in GWAS studies

Age of Onset in Schizophrenia Spectrum Disorders: Complex Interactions between Genetic and Environmental Factors

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial

CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

Clinical features and drug induced side effects in early versus late antidepressant responders

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy

Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption

Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D ⬇️

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies

Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment

Genes involved in neuroplasticity and stressful life events act on the short-term response to antidepressant treatment: a complex interplay between genetics and environment

Genetic and Environmental Contribution to Major Depressive Disorder and Self-declared Depression

Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future

Genetics of long-term treatment outcome in bipolar disorder

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: common and specific effects of key regulators of fat-mass homoeostasis genes

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders.

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis

How to Utilize Clinical and Genetic Information for Personalized Treatment of Major Depressive Disorder: Step by Step Strategic Approach

Mechanisms of antidepressant action: an integrated dopaminergic perspective

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy ⬇️

Neuronal cell adhesion genes and antidepressant response in three independent samples

No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials

Pharmacogenetics in major depression: a comprehensive meta-analysis

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research

Pharmacogenetics of antidepressant response

Pharmacogenetics of antidepressants

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.

Precision psychiatry in clinical practice

Predictors of switch from depression to mania in bipolar disorder

Progress and prospects in pharmacogenetics of antidepressant drugs

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials

Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice

Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics

Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment

Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients

Shared genetics among major psychiatric disorders ⬇️

Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples

TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

The search for personalized antidepressant treatments: what have we learned and where are we going

Uncovering neurodevelopmental features in bipolar affective disorder

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors